Induction of HIV-Specific CTL and Antibody Responses in Mice Using Retroviral Vector-Transduced Cells
Authors:
- Carol-Gay AndersonCACarol-Gay Anderson
- Lisa LaubeLLLisa Laube
- Douglas J. JollyDJDouglas J. Jolly
- Kay TownsendKTKay Townsend
- Sunil ChadaSCSunil Chada
- Daniel LouisDLDaniel Louis
- 1 August 1991
- journal article
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 7 (8) , 645-655
Abstract
Recombinant retroviral vectors can efficiently transduce and express foreign genes in mammalian cells. We have examined the utility of retroviral vector-mediated gene transfer to deliver genes which encode human immunodeficiency virus type I (HIV) antigens capable of stimulating specific immune responses. Murine fibroblast cell lines were transduced with a nonreplicating murine retroviral vector carrying the gene encoding the HIV-III B envelope protein and were shown to express the gp160/120 protein. Mice immunized with syngeneic vector-transduced cells developed CD8 + , class I major histocompatibility complex (MHC)-restricted cytotoxic T lymphocytes (CTL) specific for targets expressing the HIV envelope protein. The CTL also exhibited lytic activity on target cells coated with synthetic peptides derived from the gp120 V3 hypervariable region of both the HIV-III B and HIV MN isolates. Following adoptive transfer in a murine tumor model, these CTL were shown to be effective in vivo by their ability to eliminate established tumor cells expressing the HIV protein. Vector-transduced syngeneic cells were also capable of eliciting HIV envelope-specific antibody responses in immunized mice. Sera obtained from these mice were found to bind to the HIV-III B gp160 protein as well as a peptide-defined neutralizing antibody epitope contained within the V3 domain of gp120. These sera exhibited virus-neutralizing activity in that they markedly reduced the ability of HIV to infect and form syncytia of a human T-cell line. This is the first demonstration that cells transduced with a retroviral vector encoding the HIV-III B envelope protein are capable of inducing effective HIV-specific cellular and humoral immune responses in mice.Keywords
This publication has 49 references indexed in Scilit:
- Multiple subsets of HIV‐specific cytotoxic T lymphocytes in humans and in miceEuropean Journal of Immunology, 1989
- Human cell lines stably expressing HIV env and tat gene productsBiochemical and Biophysical Research Communications, 1989
- Introduction of soluble protein into the class I pathway of antigen processing and presentationCell, 1988
- Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4+ cells: Mechanism for persistence in AIDSCell, 1988
- Antibody to Lymphadenopathy-Associated Virus in AIDSNew England Journal of Medicine, 1985
- Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cellsNature, 1985
- Complete nucleotide sequence of the AIDS virus, HTLV-IIINature, 1985
- Transformation mediated by the SV40 T antigens: Separation of the overlapping SV40 early genes with a retroviral vectorCell, 1984
- Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDSScience, 1984
- Activity and dexamethasone sensitivity of natural cytotoxic cell subpopulationsCellular Immunology, 1982